Seeking the mysterious and subtle truth from Practice.
Cells are considered the fundamental structural and functional units of life. A tiny cell contains infinite energy, and one life generates three lives, which in turn give rise to countless more. For thousands of years, humanity has been exploring the mysteries of life. With advances in technology, while life expectancy continues to increase, many chronic degenerative diseases have emerged. The traditional medical approaches, relying on drugs and surgeries, can no longer meet the enormous demands of clinical medicine. Regenerative medicine, based on the repair and regeneration abilities of stem cells, holds the potential to address major medical challenges faced by humans, triggering a new wave of medical revolution after drugs and surgeries.
Shanghai Yuanvore Medicine Technology Co., Ltd. is a regenerative medicine company specialized in developing and applying of iPSC (induced pluripotent stem cell) technology，National science and technology small and medium-sized enterprises identification. iPSC provides unlimited possibilities for regenerative medicine with its unique ability of infinite proliferation and development totipotency. Together with the world's leading iPSC expert team, we are committed to creating the "Yuanvore Solution" - to achieve a global breakthrough in the industrialization of iPSC induction, differentiation and amplification, and to build an efficient, stable and accurate iPSC technology platform for the treatment of chronic degenerative diseases such as the nervous system, immune system and metabolic system. To solve the major health problems in the field of regenerative medicine such as aging, degeneration, and injury, and create subversive medical value and market value. At present, it has obtained 5 invention patent authorizations. Currently, it has 36 world-leading independent intellectual property rights in the three key areas of cell reprogramming, directed differentiation, and cell engineering, including 11 invention patents, 5 of which have been authorized and 2 have applied for PCT, which is the application of iPSC technology in regenerative medicine. Applications provide solutions for the treatment of chronic degenerative diseases.
We believe that better cell therapy results from better cells. Yuanvore Medicine aims to establish a "Super Cell Bank" meet the requirements of academic research, drug discovery, and cell therapy development. The quantity, quality, purity, and reproducibility of iPSCs were guaranteed by strict quality control and innovative translational techniques.
We firmly believe that technology benefits the public. With market orientation and technology as the cornerstone, Yuanvore Medicine has opened a new era of regenerative medicine from clinical medicine to health consumption by using three platform technologies of iPSC reprogramming, targeted differentiation and genetic engineering transformation to meet the general needs of cell API preparation, special needs of clinical treatment, and industrialization needs of large health market. To provide patients worldwide with reliable and affordable iPSC treatment products.